Genomic screening in children: BabyScreen+

Gene: GCK

Green List (high evidence)

GCK (glucokinase, Ensemblv90)
EnsemblGeneIds (GRCh38): ENSG00000106633
EnsemblGeneIds (GRCh37): ENSG00000106633
OMIM: 138079, ClinGen, DECIPHER
GCK is in 1 panel

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Only included here for association with MODY -- caution when reporting.
Created: 17 Dec 2025, 5:48 p.m. | Last Modified: 17 Dec 2025, 5:48 p.m.
Panel Version: 0.76

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
MODY, type II, AD (MIM#125851)

chirag patel (Genetic Health Queensland)

Green List (high evidence)

Well reported gene-disease association. Inactivating loss of function variants are associated with MODY type II (MIM#125851) and diabetes mellitus, permanent neonatal 1 (MIM#606176). Activating gain of function variants have been associated with hyperinsulinemic hypoglycemia, and usually cluster in a discrete region of the protein termed the allosteric activator site.
Created: 19 May 2022, 3:59 p.m. | Last Modified: 19 May 2022, 3:59 p.m.
Panel Version: 0.14592

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Diabetes mellitus, noninsulin-dependent, late onset, AD (MIM#125853); Diabetes mellitus, permanent neonatal 1, AR (MIM#606176); Hyperinsulinemic hypoglycemia, familial, 3, AD (MIM#602485); MODY, type II, AD (MIM#125851)

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Royal Melbourne Hospital
Phenotypes
  • MODY, type II, AD (MIM#125851)
Tags
treatable endocrine
OMIM
138079
ClinGen
GCK
DECIPHER
GCK
Clinvar variants
Variants in GCK
Penetrance
None
Publications
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
17 Dec 2025, Gel status: 3

Added Tag, Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag treatable tag was added to gene: GCK. Tag endocrine tag was added to gene: GCK.

17 Dec 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: gck has been classified as Green List (High Evidence).

17 Dec 2025, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: GCK were changed from Diabetes mellitus, noninsulin-dependent, late onset, AD (MIM#125853); Diabetes mellitus, permanent neonatal 1, AR (MIM#606176); Hyperinsulinemic hypoglycemia, familial, 3, AD (MIM#602485); MODY, type II, AD (MIM#125851) to MODY, type II, AD (MIM#125851)

17 Dec 2025, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: GCK was changed from BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

17 Dec 2025, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: GCK was added gene: GCK was added to Genomic screening in children: BabyScreen+. Sources: Expert Review Green,Royal Melbourne Hospital Mode of inheritance for gene: GCK was set to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal Publications for gene: GCK were set to 19790256 Phenotypes for gene: GCK were set to Diabetes mellitus, noninsulin-dependent, late onset, AD (MIM#125853); Diabetes mellitus, permanent neonatal 1, AR (MIM#606176); Hyperinsulinemic hypoglycemia, familial, 3, AD (MIM#602485); MODY, type II, AD (MIM#125851)